These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
289 related items for PubMed ID: 3019521
1. Biosynthesis and expression of the disialoganglioside GD2, a relevant target antigen on small cell lung carcinoma for monoclonal antibody-mediated cytolysis. Cheresh DA, Rosenberg J, Mujoo K, Hirschowitz L, Reisfeld RA. Cancer Res; 1986 Oct; 46(10):5112-8. PubMed ID: 3019521 [Abstract] [Full Text] [Related]
2. Disialoganglioside GD2 on human neuroblastoma cells: target antigen for monoclonal antibody-mediated cytolysis and suppression of tumor growth. Mujoo K, Cheresh DA, Yang HM, Reisfeld RA. Cancer Res; 1987 Feb 15; 47(4):1098-104. PubMed ID: 3100030 [Abstract] [Full Text] [Related]
3. Monoclonal antibody-defined correlations in melanoma between levels of GD2 and GD3 antigens and antibody-mediated cytotoxicity. Thurin J, Thurin M, Kimoto Y, Herlyn M, Lubeck MD, Elder DE, Smereczynska M, Karlsson KA, Clark WM, Steplewski Z. Cancer Res; 1987 Mar 01; 47(5):1229-33. PubMed ID: 3815333 [Abstract] [Full Text] [Related]
4. Anti-GD3 monoclonal antibody analysis of childhood T-cell acute lymphoblastic leukemia: detection of a target antigen for antibody-mediated cytolysis. Reaman GH, Taylor BJ, Merritt WD. Cancer Res; 1990 Jan 01; 50(1):202-5. PubMed ID: 2403416 [Abstract] [Full Text] [Related]
5. Immunocytochemical study on internalization of anti-carbohydrate monoclonal antibodies. Kusano A, Ohta S, Shitara K, Hanai N. Anticancer Res; 1993 Jan 01; 13(6A):2207-12. PubMed ID: 8297135 [Abstract] [Full Text] [Related]
6. Lysis of human tumor cell lines by canine complement plus monoclonal antiganglioside antibodies or natural canine xenoantibodies. Helfand SC, Hank JA, Gan J, Sondel PM. Cell Immunol; 1996 Jan 10; 167(1):99-107. PubMed ID: 8548851 [Abstract] [Full Text] [Related]
7. Functional properties and effect on growth suppression of human neuroblastoma tumors by isotype switch variants of monoclonal antiganglioside GD2 antibody 14.18. Mujoo K, Kipps TJ, Yang HM, Cheresh DA, Wargalla U, Sander DJ, Reisfeld RA. Cancer Res; 1989 Jun 01; 49(11):2857-61. PubMed ID: 2720646 [Abstract] [Full Text] [Related]
13. Expansion of natural killer cells in mice transgenic for IgM antibody to ganglioside GD2: demonstration of prolonged survival after challenge with syngeneic tumor cells. Kawashima I, Yoshida Y, Taya C, Shitara H, Yonekawa H, Karasuyama H, Tada N, Furukawa K, Tai T. Int J Oncol; 2003 Aug 15; 23(2):381-8. PubMed ID: 12851687 [Abstract] [Full Text] [Related]
17. Monoclonal antibodies reactive with small cell carcinoma of the lung. Ball ED, Graziano RF, Pettengill OS, Sorenson GD, Fanger MW. J Natl Cancer Inst; 1984 Mar 15; 72(3):593-8. PubMed ID: 6321841 [Abstract] [Full Text] [Related]
18. Selective cytotoxicity of the SM1 monoclonal antibody towards small cell carcinoma of the lung. Bernal SD, Mabry M, Stahel RA, Griffin JD, Speak JA. Cancer Res; 1985 Mar 15; 45(3):1026-32. PubMed ID: 2982482 [Abstract] [Full Text] [Related]